Hello and welcome to the details of Russia approves trials of combined AstraZeneca and Sputnik V vaccine and now with the details
MOSCOW, July 27 — Russia has given the green light for clinical trials combining a British shot from AstraZeneca Plc and Oxford University with Russia’s Sputnik V vaccine to go ahead, according to Russia’s state drug register. The health ministry’s ethical committee had in May suspended the approval process for the clinical trials, and requested additional information.
According to the state drug register, five Russian clinics will hold trials that are set to finish in early March, 2022.
Both the AstraZeneca/Oxford and Sputnik V vaccines involve two doses — an initial shot and a booster — but Sputnik V uses different viral vectors for its two shots.
Russian Direct Investment Fund (RDIF), which promotes the use of the Sputnik V vaccine, has welcomed the decision to go ahead with the trials.
“Currently, RDIF is conducting joint clinical trials to combine the first component of Sputnik V — the Sputnik Light vaccine — with vaccines from other foreign manufacturers,” it said in a statement.
“In particular, the Sputnik Light vaccine can be used in combination with other vaccine to increase their effectiveness including against new variants appearing as a result of the mutation of the virus.”
So-called viral vector shots use harmless modified viruses as vehicles, or vectors, to carry genetic information that helps the body build immunity against future infections.
Human trials of a Covid-19 vaccine combining the AstraZeneca/Oxford shot with Sputnik V had already been approved in Azerbaijan, the United Arab Emirates, Belarus and Argentina. — Reuters
These were the details of the news Russia approves trials of combined AstraZeneca and Sputnik V vaccine for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.